Analyses of a second group of ALS patients verified the inverse correlation of FoxP3 expression with disease progression rates; patients with low FoxP3 levels progressed more rapidly and low FoxP3 expression levels were predictive of future rapid progression rates. The gene discussed is FOXP3; the disease is amyotrophic lateral sclerosis.